The investigational drugs referenced on this website are currently in clinical development and are provided for informational purposes only. They are not intended to diagnose, cure, mitigate, treat, or prevent any disease.
Market Overview
According to Vision Research Reports, the global cancer treatment market is projected to reach USD 356.2 billion in 2025, growing to USD 814.98 billion by 2033. The compound annual growth rate (CAGR) is expected to increase from the previously estimated 8.34% to 11.3% between 2024 and 2033.
Immunotherapy represents a paradigm shift in cancer treatment, offering new strategies to enhance the immune system’s ability to recognize and eliminate cancer cells. By leveraging the body’s natural defense mechanisms, immunotherapy has the potential to deliver targeted and durable responses, with fewer side effects compared to traditional therapies.
Overall, market forecasts for immunotherapy in cancer treatment remain highly positive. The market share and value of immunotherapy have consistently increased in recent years. With continued research progress and improved clinical outcomes, immunotherapy is expected to play an increasingly critical role in the fight against cancer.
Source: Vision Research Reports, Cancer Immunotherapy, 2025
